风湿免疫指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫指南

2021 循证共识建议：IgA血管炎的达标治疗

2021-12-09 国外风湿免疫科相关专家小组 Ther Adv Musculoskelet Dis

血管炎IgA血管炎

IgA血管炎（IgAV）以前被称为过敏性紫癜，是儿童系统性血管炎最常见的原因。本文主要针对IgA血管炎的达标治疗的16个关键问题提供共识建议。

中文标题：

2021 循证共识建议：IgA血管炎的达标治疗

英文标题：

Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis

发布机构：

国外风湿免疫科相关专家小组

发布日期：

2021-12-09

简要介绍：

IgA血管炎（IgAV）以前被称为过敏性紫癜，是儿童系统性血管炎最常见的原因。本文主要针对IgA血管炎的达标治疗的16个关键问题提供共识建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 循证共识建议：IgA血管炎的达标治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7eff01c0022965a0, title=2021 循证共识建议：IgA血管炎的达标治疗, enTitle=Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis, guiderFrom=Ther Adv Musculoskelet Dis, authorId=0, author=, summary=IgA血管炎（IgAV）以前被称为过敏性紫癜，是儿童系统性血管炎最常见的原因。本文主要针对IgA血管炎的达标治疗的16个关键问题提供共识建议。, cover=https://img.medsci.cn/20211220/1639974181035_1608702.jpg, journalId=0, articlesId=null, associationId=893, associationName=国外风湿免疫科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Thu Dec 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">IgA血管炎（IgAV）以前被称为过敏性紫癜，是儿童系统性血管炎最常见的原因。本文主要针对IgA血管炎的达标治疗的16个关键问题提供共识建议。</span></p>, tagList=[TagDto(tagId=1786, tagName=血管炎), TagDto(tagId=61008, tagName=IgA血管炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21023, categoryName=赛诺菲-赛能, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=61008, guiderKeyword=IgA血管炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6044, appHits=243, showAppHits=0, pcHits=1694, showPcHits=5797, likes=2, shares=20, comments=8, approvalStatus=1, publishedTime=Mon Dec 20 12:18:08 CST 2021, publishedTimeString=2021-12-09, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Dec 20 12:28:11 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 09:44:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 循证共识建议：IgA血管炎的达标治疗.pdf)])
2021 循证共识建议：IgA血管炎的达标治疗.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2152426, encodeId=1e89215242624, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=012f8813795, createdName=ms7000001804992894, createdTime=Sat Aug 12 14:29:12 CST 2023, time=2023-08-12, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1198958, encodeId=39fc119895803, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Mar 03 09:24:47 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083778, encodeId=e0ec1083e78c6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc766415366, createdName=ms5000001063981128, createdTime=Fri Dec 24 08:32:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082518, encodeId=92401082518f9, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ccd1831345, createdName=ms1582340189798120, createdTime=Tue Dec 21 11:23:06 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082316, encodeId=26821082316bb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:02:20 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2023-08-12 ms7000001804992894 来自日本

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2152426, encodeId=1e89215242624, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=012f8813795, createdName=ms7000001804992894, createdTime=Sat Aug 12 14:29:12 CST 2023, time=2023-08-12, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1198958, encodeId=39fc119895803, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Mar 03 09:24:47 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083778, encodeId=e0ec1083e78c6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc766415366, createdName=ms5000001063981128, createdTime=Fri Dec 24 08:32:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082518, encodeId=92401082518f9, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ccd1831345, createdName=ms1582340189798120, createdTime=Tue Dec 21 11:23:06 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082316, encodeId=26821082316bb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:02:20 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-03-03 taken110

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2152426, encodeId=1e89215242624, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=012f8813795, createdName=ms7000001804992894, createdTime=Sat Aug 12 14:29:12 CST 2023, time=2023-08-12, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1198958, encodeId=39fc119895803, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Mar 03 09:24:47 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083778, encodeId=e0ec1083e78c6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc766415366, createdName=ms5000001063981128, createdTime=Fri Dec 24 08:32:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082518, encodeId=92401082518f9, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ccd1831345, createdName=ms1582340189798120, createdTime=Tue Dec 21 11:23:06 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082316, encodeId=26821082316bb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:02:20 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-24 ms5000001063981128

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2152426, encodeId=1e89215242624, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=012f8813795, createdName=ms7000001804992894, createdTime=Sat Aug 12 14:29:12 CST 2023, time=2023-08-12, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1198958, encodeId=39fc119895803, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Mar 03 09:24:47 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083778, encodeId=e0ec1083e78c6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc766415366, createdName=ms5000001063981128, createdTime=Fri Dec 24 08:32:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082518, encodeId=92401082518f9, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ccd1831345, createdName=ms1582340189798120, createdTime=Tue Dec 21 11:23:06 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082316, encodeId=26821082316bb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:02:20 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 ms1582340189798120

    受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2152426, encodeId=1e89215242624, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=012f8813795, createdName=ms7000001804992894, createdTime=Sat Aug 12 14:29:12 CST 2023, time=2023-08-12, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1198958, encodeId=39fc119895803, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Mar 03 09:24:47 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083778, encodeId=e0ec1083e78c6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc766415366, createdName=ms5000001063981128, createdTime=Fri Dec 24 08:32:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082518, encodeId=92401082518f9, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ccd1831345, createdName=ms1582340189798120, createdTime=Tue Dec 21 11:23:06 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082316, encodeId=26821082316bb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:02:20 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 微探

    学习学习

    0

相关指南

抗中性粒细胞胞质抗体相关肾炎诊断和治疗中国指南

中华医学会肾脏病学分会 · 2021-07-03